[go: up one dir, main page]

UY32638A - Manoproteínas para uso en zumo de frutas - Google Patents

Manoproteínas para uso en zumo de frutas

Info

Publication number
UY32638A
UY32638A UY0001032638A UY32638A UY32638A UY 32638 A UY32638 A UY 32638A UY 0001032638 A UY0001032638 A UY 0001032638A UY 32638 A UY32638 A UY 32638A UY 32638 A UY32638 A UY 32638A
Authority
UY
Uruguay
Prior art keywords
fruit juice
manoproteins
mannoprotein
taste
fruit
Prior art date
Application number
UY0001032638A
Other languages
English (en)
Inventor
Dr Eckhard Bender
Dr Katja Zimmermann
Gerdes Dr Christoph
Dr Mark Jean Gnoth
Dr Susanne Roehrig
Dr Yolanda Cancho-Grande
Buchmueller Dr Anja
Original Assignee
Dsm Ip Assets Bv
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Dsm Ip Assets Bv filed Critical Dsm Ip Assets Bv
Publication of UY32638A publication Critical patent/UY32638A/es

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
    • C07D413/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings
    • C07D413/04—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings directly linked by a ring-member-to-ring-member bond
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/535—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one oxygen as the ring hetero atoms, e.g. 1,2-oxazines
    • A61K31/5375—1,4-Oxazines, e.g. morpholine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/14—Vasoprotectives; Antihaemorrhoidals; Drugs for varicose therapy; Capillary stabilisers
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
    • C07D413/14—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing three or more hetero rings

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Cardiology (AREA)
  • Vascular Medicine (AREA)
  • Hematology (AREA)
  • Diabetes (AREA)
  • Urology & Nephrology (AREA)
  • Pain & Pain Management (AREA)
  • Rheumatology (AREA)
  • Epidemiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Hydrogenated Pyridines (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Non-Alcoholic Beverages (AREA)

Abstract

La presente invención se relaciona con el uso de manoproteína para la estabilización de zumo de frutas. La manoproteína puede ser utilizada de manera efectiva para estabilizar los zumos de fruta. Puede no tener efectos indeseables en el gusto, sabor, apariencia o textura del zumo de fruta. El uso de la manoproteína puede ser simple y no costoso.
UY0001032638A 2009-05-18 2010-05-13 Manoproteínas para uso en zumo de frutas UY32638A (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP09160494 2009-05-18
DE102009022896A DE102009022896A1 (de) 2009-05-27 2009-05-27 Substituierte Piperidine

Publications (1)

Publication Number Publication Date
UY32638A true UY32638A (es) 2010-10-29

Family

ID=42543057

Family Applications (2)

Application Number Title Priority Date Filing Date
UY0001032638A UY32638A (es) 2009-05-18 2010-05-13 Manoproteínas para uso en zumo de frutas
UY0001032636A UY32636A (es) 2009-05-27 2010-05-13 Piperidinas sustituidas

Family Applications After (1)

Application Number Title Priority Date Filing Date
UY0001032636A UY32636A (es) 2009-05-27 2010-05-13 Piperidinas sustituidas

Country Status (28)

Country Link
US (2) US20120220563A1 (es)
EP (1) EP2435427A1 (es)
JP (1) JP5718320B2 (es)
KR (1) KR20120044289A (es)
CN (2) CN104744452A (es)
AR (1) AR076692A1 (es)
AU (1) AU2010252345A1 (es)
BR (1) BRPI1012055A2 (es)
CA (1) CA2763400A1 (es)
CL (1) CL2011002965A1 (es)
CO (1) CO6470823A2 (es)
CR (1) CR20110628A (es)
CU (1) CU20110215A7 (es)
DE (1) DE102009022896A1 (es)
DO (1) DOP2011000364A (es)
EA (1) EA201190312A1 (es)
EC (2) ECSP11011483A (es)
GT (1) GT201100300A (es)
IL (1) IL215901A0 (es)
MA (1) MA33290B1 (es)
MX (1) MX2011012505A (es)
PE (1) PE20120934A1 (es)
SG (1) SG175753A1 (es)
TN (1) TN2011000595A1 (es)
TW (1) TW201109326A (es)
UY (2) UY32638A (es)
WO (1) WO2010136144A1 (es)
ZA (1) ZA201108565B (es)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE102009014484A1 (de) 2009-03-23 2010-09-30 Bayer Schering Pharma Aktiengesellschaft Substituierte Piperidine
DE102009022896A1 (de) 2009-05-27 2010-12-02 Bayer Schering Pharma Aktiengesellschaft Substituierte Piperidine
DE102009022892A1 (de) * 2009-05-27 2010-12-02 Bayer Schering Pharma Aktiengesellschaft Substituierte Piperidine
DE102009022894A1 (de) * 2009-05-27 2010-12-02 Bayer Schering Pharma Aktiengesellschaft Substituierte Piperidine
SG2014010417A (en) 2011-10-07 2014-06-27 Takeda Pharmaceutical 1 - arylcarbonyl - 4 - oxy - piperidine compounds useful for the treatment of neurodegenerative diseases
MX381425B (es) 2016-04-20 2025-03-12 Bristol Myers Squibb Co Compuestos heterociclicos biciclicos sustituidos.
ES2902527T3 (es) 2016-11-03 2022-03-28 Bristol Myers Squibb Co Derivados biciclo heterocíclicos sustituidos, útiles como inhibidores del canal ROMK
MY201325A (en) 2017-06-01 2024-02-16 Bristol Myers Squibb Co Substituted nitrogen containing compounds
WO2023044364A1 (en) 2021-09-15 2023-03-23 Enko Chem, Inc. Protoporphyrinogen oxidase inhibitors

Family Cites Families (22)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5767144A (en) * 1994-08-19 1998-06-16 Abbott Laboratories Endothelin antagonists
AU2722297A (en) 1996-04-03 1997-10-22 Merck & Co., Inc. Piperidines, pyrrolidines and hexahydro-1h-azepines promote release of growth hormone
US6403612B2 (en) * 2000-01-31 2002-06-11 Merck & Co., Inc. Thrombin receptor antagonists
MXPA04003480A (es) 2001-10-15 2004-07-30 Janssen Pharmaceutica Nv Derivados de 4-fenil-4-(1h-imidazol-2-il)-piperidina sustituida para la reduccion de la lesion isquemica.
US7319104B2 (en) * 2002-03-01 2008-01-15 Smithkline Beecham Corporation hPPARs activators
US8071624B2 (en) 2004-06-24 2011-12-06 Incyte Corporation N-substituted piperidines and their use as pharmaceuticals
CA2589565A1 (en) 2004-06-24 2006-01-05 Incyte Corporation Amido compounds and their use as pharmaceuticals
JP2008504278A (ja) 2004-06-24 2008-02-14 インサイト・コーポレイション アミド化合物およびその医薬としての使用
CN1993128A (zh) * 2004-06-24 2007-07-04 因塞特公司 N－取代的哌啶及它们作为药物的用途
WO2006020598A2 (en) 2004-08-10 2006-02-23 Incyte Corporation Amido compounds and their use as pharmaceuticals
JP2007008913A (ja) * 2004-09-17 2007-01-18 Tanabe Seiyaku Co Ltd ピペリジン化合物およびその製法
DE102004045796A1 (de) * 2004-09-22 2006-03-23 Merck Patent Gmbh Arzneimittel enthaltend Carbonylverbindungen sowie deren Verwendung
DE102004061750A1 (de) * 2004-12-22 2006-07-06 Bayer Healthcare Ag Heteroaryl-substituierte Pyrazoline
CA2621255A1 (en) 2005-09-21 2007-04-05 Incyte Corporation Amido compounds and their use as pharmaceuticals
TW200804341A (en) 2006-01-31 2008-01-16 Incyte Corp Amido compounds and their use as pharmaceuticals
US20070213311A1 (en) 2006-03-02 2007-09-13 Yun-Long Li Modulators of 11-beta hydroxyl steroid dehydrogenase type 1, pharmaceutical compositions thereof, and methods of using the same
EP2013163A1 (en) 2006-05-01 2009-01-14 Incyte Corporation Tetrasubstituted ureas as modulators of 11-beta hydroxyl steroid dehydrogenase type 1
ATE506359T1 (de) 2007-11-30 2011-05-15 Bayer Schering Pharma Ag Heteroaryl-substituierte piperidine
DE102009014484A1 (de) * 2009-03-23 2010-09-30 Bayer Schering Pharma Aktiengesellschaft Substituierte Piperidine
DE102009022896A1 (de) 2009-05-27 2010-12-02 Bayer Schering Pharma Aktiengesellschaft Substituierte Piperidine
DE102009022894A1 (de) * 2009-05-27 2010-12-02 Bayer Schering Pharma Aktiengesellschaft Substituierte Piperidine
DE102009022897A1 (de) * 2009-05-27 2010-12-02 Bayer Schering Pharma Aktiengesellschaft Substituierte Piperidine

Also Published As

Publication number Publication date
CN102596944B (zh) 2015-08-26
SG175753A1 (en) 2011-12-29
CU20110215A7 (es) 2012-03-15
JP5718320B2 (ja) 2015-05-13
CA2763400A1 (en) 2010-12-02
UY32636A (es) 2010-12-31
AR076692A1 (es) 2011-06-29
CO6470823A2 (es) 2012-06-29
ECSP11011482A (es) 2011-12-30
CR20110628A (es) 2012-03-22
IL215901A0 (en) 2012-01-31
DE102009022896A1 (de) 2010-12-02
US20110021489A1 (en) 2011-01-27
WO2010136144A1 (de) 2010-12-02
US8084469B2 (en) 2011-12-27
TW201109326A (en) 2011-03-16
PE20120934A1 (es) 2012-08-01
MX2011012505A (es) 2011-12-14
JP2012528090A (ja) 2012-11-12
DOP2011000364A (es) 2012-02-29
EP2435427A1 (de) 2012-04-04
ECSP11011483A (es) 2011-12-30
TN2011000595A1 (en) 2013-05-24
KR20120044289A (ko) 2012-05-07
CN104744452A (zh) 2015-07-01
MA33290B1 (fr) 2012-05-02
CL2011002965A1 (es) 2012-07-06
ZA201108565B (en) 2013-01-30
CN102596944A (zh) 2012-07-18
BRPI1012055A2 (pt) 2016-05-17
US20120220563A1 (en) 2012-08-30
AU2010252345A1 (en) 2011-12-08
EA201190312A1 (ru) 2012-05-30
GT201100300A (es) 2013-08-21

Similar Documents

Publication Publication Date Title
UY32638A (es) Manoproteínas para uso en zumo de frutas
MX2013010690A (es) Composicion de glicosido de esteviol glucosilado como un aumentador de gusto y sabor.
GT200800012A (es) Producto de bebida con edulcorante no alimenticio y desnaturalizante
MX367392B (es) Composiciones y productos comestibles.
MX2016006684A (es) Productos alimenticios y bebidas que contienen alulosa (psicosa).
MX2015008646A (es) Composiciones de sabor y composiciones comestibles que contienen las mismas.
GT200800027A (es) Productos de bebida con glucosidos de esteviol y al menos un acido
IN2014DN07838A (es)
BR112013020511A2 (pt) composição de estévia
BR112017010868A2 (pt) composição adoçante
MX357730B (es) Extractos enriquecidos de componentes de alimentos y bebidas.
MX2019004596A (es) Composicion de estevia.
PE20171642A1 (es) Alimentos y bebidas saborizados
MX2024009298A (es) Composiciones que comprenden rebaudiosido j
MX373929B (es) Composiciones y metodos para mejorar la solubilidad del rebaudiosido x.
CO6310999A2 (es) Derivados de isosorbide y uso como modificadores de sabor condimentadores e intensificadores de sabor
MX380193B (es) Edulcorante mejorado.
CL2011001588A1 (es) Uso de un producto que comprende un agente edulcorante derivado de stevia rebaudiana que comprende rebaudiosida y solidos de aspalathis linearis; que reduce o elimina el sabor amargo del agente edulcorante; metodo para fabricar dicho producto.
MX376950B (es) D-psicosa en bebidas congeladas de cero o bajas calorías.
MX2016003540A (es) Glicosido de esteviol glucosilado como un modificador de sabor.
CL2018000345A1 (es) Composición que comprende compuestos de modulación del gusto, su uso y productos alimenticios que los contienen
MX2016002991A (es) Aceitunas envasadas sin salmuera con una acidez baja.
MX2013004371A (es) Cisteina y consumo de alimentos.
PH12018501676A1 (en) Composition having rich-taste imparting function
MX2021003887A (es) Composicion de estevia.

Legal Events

Date Code Title Description
104 Application deemed to be withdrawn (no substantive examination fee paid)

Effective date: 20110620